UK markets open in 3 hours 8 minutes

Lifevantage Corporation (LFVN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.77+0.20 (+3.04%)
At close: 04:00PM EDT
6.77 0.00 (0.00%)
After hours: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close6.57
Open6.78
Bid0.00 x 0
Ask6.82 x 100
Day's range6.68 - 7.00
52-week range3.75 - 8.69
Volume85,729
Avg. volume34,933
Market cap87.12M
Beta (5Y monthly)N/A
PE ratio (TTM)27.08
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield0.16 (2.44%)
Ex-dividend date31 May 2024
1y target estN/A
All
News
  • GlobeNewswire

    LifeVantage to Participate in the Sidoti Micro Cap Conference

    SALT LAKE CITY, May 06, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer, and Carl Aure, Chief Financial Officer, will participate in the Sidoti Micro Cap Conference, to be held May 8-9, 2024. Mr. Fife and Mr. Aure will meet with investors and present at approximately 1:00 p.m. Eastern Time o

  • GlobeNewswire

    LifeVantage Declares Quarterly Dividend

    SALT LAKE CITY, May 02, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of $0.04 per share of common stock, which will be paid June 14, 2024 to all stockholders of record at the close of business on May 31, 2024. This represents an increase in the dividend amount by 14.

  • GlobeNewswire

    LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2024

    SALT LAKE CITY, May 02, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2024. Third Quarter Fiscal 2024 Summary*: Revenue of $48.2 million, a decrease of 10.2% from the prior year period. Excluding the negative impact of foreign currency fluctuations, third quarter revenue was down a